News Categories
Resources For Living
Mesothelioma Forum
Legal Help Blog
Find a Doctor Near You
Mesothelioma Blog
Latest News
- Second-Hand Asbestos Exposure Responsible for Some Mesothelioma Cases
- Lab-on-Bead Offers Potential to Quickly Develop New Treatment for Mesothelioma
- “Rock for Doc” Concert Held to Raise Money for Doctor’s Mesothelioma Treatments
- NY Mesothelioma and Asbestos Attorney Applauds Changes to City’s Building Inspection Oversight
- Mesothelioma Patient Cancer-Free Five Years After Innovative Treatment
- University of Arizona’s Cancer Center Hopes to Become Premier Mesothelioma Treatment Facility in the Southwest
- SBRT, Useful for Treating Mesothelioma, to be Discussed at 2010 ASTRO Conference
- British Man Fights Mesothelioma by Running
- Ogdensburg Receives Grant Money to Demolish Buildings Known to Contain Mesothelioma-Causing Asbestos
- ADI-PEG 20 Shows Promise in Inhibiting Mesothelioma Cancer Cell Growth
Thursday, December 10, 2009
Another new mesothelioma drug clinical trial is slated to begin in December 2009. Australian drug maker Bionomics Ltd plans to conduct a Phase II clinical trial of its anti-cancer drug BNC105. They will conduct the tests on 60 mesothelioma patients in Australia.
The drug has shown great promise thus far by killing cancer cells when testing with solid tumors in animals. Bionomics believes patients will not become resistant to this drug as often happens with other chemotherapy treatments. BNC105 will also undergo a Phase II trial in the United States for the treatment of renal cancer.
The primary goal of this study is to determine the safety and maximum tolerated dose of BNC105 in patients with advanced solid tumors. Bionomics says BNC105 “can extend the life of people suffering from mesothelioma and provide them with a better quality of life.”
Sources:
Bionomics Clinical Trials
The Sydney Morning Herald
© MesotheliomaHelp.Net. All Rights Reserved. Reprinting or republication of this article or any portion of its content is permitted but must include the MesotheliomaHelp.Net link.
Labels: ClinicalTrial, mesothelioma
posted by Nancy Meredith at 7:00 AM
